John Wrobleski

John Wrobleski is a seasoned quality control professional with extensive experience in the biotechnology and life sciences sectors. Currently serving as a QC Supervisor for the Analytical QC Cell Gene Therapy group at Miltenyi Biotec since July 2022, John has held various roles including QC Analyst III at MacroGenics, QA Specialist at Kaztronix (contracted to Novavax), and Senior Quality Control Specialist at Canon BioMedical and Canon US Life Sciences. Prior experience includes positions at Thermo Fisher Scientific, Life Technologies, Dako, and Aalto Scientific, where John contributed to critical quality control processes, compliance with cGMP standards, and testing of immunohistochemical reagents. John holds a Bachelor of Science degree in General Biology from UC San Diego, completed in 2001.